Cronex.Co.,Ltd (XKON:215570)

Market Cap	1.47B
Revenue	n/a
Net Income	n/a
Shares Out	3.19M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	256
Average Volume	3,610
Open	460.00
Previous Close	460.00
Day's Range	460.00 - 460.00
52-Week Range	300.00 - 749.00
Beta	-0.35
RSI	43.30
Earnings Date	n/a

About Cronex.Co.,Ltd

Cronex.Co.,Ltd engages in the research and development of medicines and raw materials for medical research. The company offers contract research organization services for dental materials, various implant materials, bone marrow restorations, and bone regeneration, skin penetration, high-frequency therapy device, patch drug test, biological dressing material, wound dressing, franz diffusion test skin; spinal implant efficacy evaluation, bone defect bone graft material efficacy evaluation, cartilage regeneration efficacy evaluation, X-ray, micro-...

• Industry: Commercial Physical and Biological Research
• Founded: 2012
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 215570